Drug Delivery Letters

Scopus Cite Score: 1.1

Indexed in: Scopus, Cabell's Directory/Journalytics

View All
Aims and Scope:
Drug Delivery Letters publishes short papers and mini-reviews in all important aspects of drug delivery, gene delivery, and drug targeting. Short papers report seminal results and research approaching conclusion of importance in the field. The journals’ scope covers all the basic and applied research in drug delivery and targeting at molecular and cellular levels and novel delivery systems. The manuscript submission process is fully electronic to ensure rapid publication of research results.
Read more...
Start Submission Button Icon

Editor-in-Chief:

  • Maria Camilla BergonziDepartment of Chemistry
    University of Florence
    Florence
    Italy

ISSN: 2210-3031 (Print)

eISSN: 2210-304X (Online)

Special Issues With Active Call for Papers

Submission closes on: Mar 04, 2027
Chitosan-Based Nano-medicines for Cancer Management: Molecular Design to Clinical Translational

Cancer constitutes a major cause of mortality globally. According to the International Agency for Cancer Research (IARC), the new cases of cancer are predicted to increase over the next ten years. Despite tremendous progress in the treatment of cancer, some hurdles, such as systemic toxicity, poor tumor targeting, multidrug resistance, and poor bioavailability, still exist. The application of nanotechnology has transformed drug delivery systems by enabling targeted drug delivery, controlled release, and enhanced permeability and... see more

Guest Editor(s): Dr. Tarun Virmani
Co-Guest Editor(s): Dr. Girish Kumar
Start Submission
Submission closes on: Feb 18, 2027
Hybrid Nano-Formulations for Spatiotemporal, Multi-Target Therapeutics: Innovations, Mechanisms, and Clinical Horizons.

Hybrid nano-formulations represent a rapidly evolving frontier in drug delivery, enabling precise spatiotemporal control and multi-target therapeutic action. By integrating organic, inorganic, polymeric, lipid-based, and biomolecular components into a single platform, these systems overcome limitations of conventional therapies such as poor bioavailability, off-target toxicity, and limited therapeutic efficacy. This thematic issue focuses on recent innovations in hybrid nano-formulations designed for site-specific, stimuli-responsive, and time-controlled drug release across diverse disease conditions. It highlights underlying mechanisms of... see more

Guest Editor(s): Dr. Khalid Bashir Mir
Co-Guest Editor(s): Dr. Faheem Hyder Pottoo,Dr. Mohit Agrawal,Dr. Narender Yadav
Start Submission